Benitec Biopharma Inc. is a clinical-stage biotechnology company headquartered in Hayward, California, developing novel genetic medicines using its proprietary DNA-directed RNA interference (ddRNAi) and 'silence and replace' technology. Its lead product, BB-301, is an AAV9-based gene therapy for Oculopharyngeal Muscular Dystrophy (OPMD), designed to permanently silence the disease-causing PABPN1 gene and replace it with a functional version in a single administration. BB-301 has received Orphan Drug and Fast Track Designations in the U.S. and Orphan Drug Designation in the EU.
expected 2026-12-14
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-09-14 | 2026-06-30 | 0001193125-26-390570 | EDGAR | 60K words |
| 2025-09-22 | 2025-06-30 | 0001193125-25-211361 | EDGAR | 80K words |
| 2024-09-26 | 2024-06-30 | 0001193125-24-226968 | EDGAR | 74K words |
| 2023-09-21 | 2023-06-30 | 0001193125-23-239121 | EDGAR | 79K words |
| 2022-09-02 | 2022-06-30 | 0001193125-22-237075 | EDGAR | — |
| 2021-09-20 | 2021-06-30 | 0001193125-21-276758 | EDGAR | — |
| 2020-09-23 | 2020-06-30 | 0001193125-20-252381 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-12 | 2025-12-31 | 0001193125-26-047737 | EDGAR | 23K words |
| 2025-11-14 | 2025-09-30 | 0001193125-25-283274 | EDGAR | 23K words |
| 2025-05-14 | 2025-03-31 | 0001193125-25-119383 | EDGAR | 29K words |
| 2025-02-14 | 2024-12-31 | 0001193125-25-026631 | EDGAR | 27K words |
| 2024-11-14 | 2024-09-30 | 0001193125-24-258672 | EDGAR | 26K words |
| 2024-05-13 | 2024-03-31 | 0001193125-24-136727 | EDGAR | 37K words |
| 2024-02-13 | 2023-12-31 | 0001193125-24-032940 | EDGAR | 34K words |
| 2023-11-13 | 2023-09-30 | 0001193125-23-275377 | EDGAR | 33K words |
| 2023-05-15 | 2023-03-31 | 0001193125-23-144211 | EDGAR | 22K words |
| 2023-02-13 | 2022-12-31 | 0001193125-23-034339 | EDGAR | 22K words |
| 2022-11-10 | 2022-09-30 | 0001193125-22-281978 | EDGAR | — |
| 2022-05-16 | 2022-03-31 | 0001193125-22-150924 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-24 | 0001193125-26-401110 | EDGAR | 1K words |
| 2026-09-14 | 0001193125-26-390539 | EDGAR | 3K words |
| 2026-02-12 | 0001193125-26-047742 | EDGAR | 3K words |
| 2025-12-02 | 0001193125-25-305475 | EDGAR | 1K words |
| 2025-11-14 | 0001193125-25-283351 | EDGAR | 3K words |
| 2025-11-07 | 0001193125-25-270490 | EDGAR | 1K words |
| 2025-11-03 | 0001193125-25-261665 | EDGAR | 4K words |
| 2025-09-22 | 0001193125-25-211462 | EDGAR | 2K words |
| 2025-09-12 | 0000950170-25-114530 | EDGAR | 1K words |
| 2025-07-09 | 0001193125-25-157095 | EDGAR | 1K words |
135 total filings indexed. 106 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001808898 |
| Ticker | BNTC |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Headquarters | Hayward, California |
| Website | https://www.benitec.com |
| Listed | 2012-07-11 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/BNTC (~200 tokens, structured JSON with cryptographic provenance)